Abstract:Objective To analyze the clinical efficacy of CO 2 fractional laser combined with compound betamethasone in treating vitiligo and its impact on inflammatory factors. Methods The clinical treatment effects, levels of inflammatory factors [interleukin-17 (IL-17), interferon-gamma (IFN-γ), interleukin-10 (IL-10)], prognosis regarding repigmentation and relapse, psychological health (satisfaction). Results 1 Clinical treatment effects: the total effective rate in Group A was 92.73%, Group B was 74.55%, and Group C was 67.27%, with Group A showing significantly higher effectiveness than Groups B and C ( p < 0.05). 2 Inflammatory factors: prior to treatment, there was no significant difference in IL-17, IFN-γ, and IL-10 levels among the three groups ( p > 0.05); after 3 and 6 months of treatment, the levels of IL-17 and IFN-γ decreased significantly while IL-10 levels increased significantly across all three groups, with Group A showing a more pronounced change compared to Groups B and C ( p < 0.05). 3 Prognosis regarding repigmentation and relapse: after 3 and 6 months of treatment, Group A exhibited significantly higher repigmentation rates compared to Groups B and C ( p < 0.05); in terms of relapse, Group A had a relapse rate of 5.45%, Group B had 21.82%, and Group C had 23.64%, with Group A showing significantly lower relapse rates compared to Groups B and C ( p < 0.05). 4 Quality of life and psychological health: at the end of the 6 month follow-up, the quality of life and psychological health of patients in Group A were significantly higher than those in Groups B and C ( p < 0.05). 5 Occurrence of adverse reactions: the incidence of adverse reactions was 12.73% in Group A, 10.91% in Group B, and 9.09% in Group C, with no significant difference observed among the three groups ( p > 0.05). Conclusion The application of CO 2 fractional laser combined with compound betamethasone in vitiligo patients demonstrates significant efficacy. Compared to sole treatment with CO 2 fractional laser or compound betamethasone injections, this combined approach further improves the levels of inflammatory factors in vitiligo patients, reduces the risk of relapse, enhances skin repigmentation, improves quality of life, psychological well-being, without increasing the risk of related adverse reactions. This combined approach merits clinical promotion and application.

Effect of calcipotriol betamethasone ointment on treatment of non-generalized vitiligo

Calcipotriol Betamethasone Ointment in the Treatment of Psoriasis Vulgaris: a Randomized, Double-Blind, Active-Controlled, Parallel Group Study.

Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Calcipotriol Scalp Solution In The Treatment Of Scalp Psoriasis: A Randomized, Controlled Trial Investigating Efficacy And Safety In A Chinese Population

The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: A systematic review and meta-analysis

Topical tacrolimus therapy for vitiligo

Comparison of Safety and Efficacy Between Calcipotriol Plus Betamethasone Dipropionate Gel and Calcipotriol Scalp Solution As Long-Term Treatment for Scalp Psoriasis in Chinese Patients: a National, Multicentre, Prospective, Randomized, Active-Controlled Phase 4 Trial

An Investigator‐masked Comparison of the Efficacy and Safety of Twice Daily Applications of Calcitriol 3 Μg/g Ointment Vs. Calcipotriol 50 Μg/g Ointment in Subjects with Mild to Moderate Chronic Plaque‐type Psoriasis

A placebo-controlled clinical trial of tacalcitol for the treatment of vitiligo

Effect of daivobet® on the quality of life in chinese patients with stable psoriasis vulgaris: A multicenter, randomized, double-blind, positive controlled and parallel group study

Ablative Fractional Co2 Laser Aided Delivery of Long-Acting Glucocorticoid in the Treatment of Acral Vitiligo: a Multicenter, Prospective, Self-Bilateral Controlled Study

Assessing effectiveness of adding niosomal atorvastatin 1% ointment to topical calcineurin inhibitor treatment in non‐segmental vitiligo

Efficacy, Safety, and Cost-Effectiveness of All-Trans Retinoic Acid/clobetasol Propionate Compound Ointment in the Treatment of Mild to Moderate Psoriasis Vulgaris: A Randomized, Single-Blind, Multicenter Clinical Trial.

Comparison between Tab Tofacitinib and Low-Dose Oral Steroid in Patients Having Vitiligo Over 6 Months

Topical tacalcitol and MEL308 nm:a synergistic combination for the treatment of vitiligo

Clinical efficacy of CO2 fractional laser combined with compound betamethasone in treating vitiligo and its impact on inflammatory factors

Therapeutic Effect of Topical Tacrolimus in Vitiligo Treatment

Effect of Calcipotriol on Melanin Synthesis by Human Melanoeytes

Low systemic exposure and calcemic effect of calcipotriol/betamethasone ointment in rats with imiquimod-induced psoriasis-like dermatitis

Combination of Calcipotriol and Halcinonide in the Treatment of Psoriasis Vulgaris

Impact of Combined Phototherapy and Melanocyte Transplantation on Indicators of Vitiligo Activity

Clinical efficacy observation of calcipotriol combined with AYJ sodium alginate repair dressing in the treatment of psoriasis vulgaris and its effect on patients' neurological function